U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. Reports, Manuals, & Forms
  4. Reports
  5. Economic Impact Analyses of FDA Regulations
  6. Summary: Postmarketing Safety Reports for Human Drug and Biological Products; Electronic Submission Requirements (Final Rule)
  1. Economic Impact Analyses of FDA Regulations

Summary: Postmarketing Safety Reports for Human Drug and Biological Products; Electronic Submission Requirements (Final Rule)

The Food and Drug Administration amends its postmarketing safety reporting regulations for human drug and biological products to require that persons subject to mandatory reporting requirements submit safety reports in an electronic format that FDA can process, review, and archive. FDA is taking this action to improve the Agency's systems for collecting and analyzing postmarketing safety reports.

Regulatory Impact Analysis

Postmarketing Safety Reports for Human Drug and Biological Products; Electronic Submission Requirements (Final Rule) (PDF - 460 KB)

Federal Register:  79 FR 33072 -33092, June 10, 2014

Docket: FDA-2008-N-0334

   
Back to Top